Condition
Inhaled Nitric Oxide
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 2 (1)
Trial Status
Completed2
Terminated1
Unknown1
Not Yet Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06832163Not ApplicableNot Yet Recruiting
Close Loop Smart Weaning for INO With PPHN
NCT04606407Not ApplicableCompleted
Inhaled NO for the Treatment of Viral Pneumonia in Adults
NCT04397692Not ApplicableTerminated
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
NCT04988932Not ApplicableCompleted
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
NCT03873298Phase 2Unknown
Inhaled NO in IPF and COPD During 6 Minute Walk Test
Showing all 5 trials